ArticleEClinicalMedicine2026

Short-term versus long-course neoadjuvant chemotherapy for resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results from the second randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.

Michele Reni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.